Targeted integration of a DNA transposon-based nonviral vector
Targeted integration of a DNA transposon-based nonviral vector
批准号:
8598929
负责人:
PATRICK L SINN
金额:
$33.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31
关键词:
AddressAnimal ModelBindingBioinformaticsCategoriesCellsChimeric ProteinsCollaborationsCystic FibrosisDNA Transposable ElementsDNA TransposonsDataDiseaseEngineeringExcisionFeline Immunodeficiency VirusFutureGene DeliveryGene Transduction AgentGene TransferGenesGeneticGenomeGenomic DNAGenomicsGoalsHumanHybridsIn VitroInsertional MutagenesisIntegraseLactonesLentivirus VectorMapsMediatingMethodsModificationMolecular GeneticsNon-Viral VectorOxidasesPatternPlasmidsProteinsPseudogenesSafetySequence AnalysisSiteSomatic CellSubfamily lentivirinaeSystemTherapeuticTransgenesTransposaseViral VectorZinc Fingersairway epitheliumbasecellular transductiondeep sequencingdesignefficacy testinggene therapygene transfer vectorimprovedin vivomutantnovelpreventsuccesstherapeutic genetoolvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Objective. Gene therapy has the potential to permanently correct or prevent monogenic disorders such
as cystic fibrosis. We have a demonstrated track record of utilizing many categories of viral and non-viral
vectors to deliver genes to the airways; however, choosing the best gene therapy vector leads to a very
significant dilemma. Non-integrating vectors may not persist and integrating vectors may cause
insertional mutagenesis. There is a critical need for improved gene delivery tools that address this
conundrum. Our long-term goal is to engineer a vehicle for gene delivery to cells that is a safe and
effective therapeutic for cystic fibrosis. To this end, the goal for these proposed studies is to develop an
integrating vector with a predictable integration pattern that targets 'safe harbor' genomic loci. Nonviral
vector systems are used increasingly as tools for gene transfer applications. We successfully used the
piggyBac DNA transposon system as an effective integrating vector for gene transfer.
Method. Based on our preliminary studies, piggyBac transposase is amenable to modification.
Furthermore, recent advances in the ability to engineer customized zinc finger proteins make the
possibility of targeted transposition promising as a therapeutic approach. The overall hypothesis is that
the piggyBac transposon system may be modified to retarget integration. We will use multiple
approaches to direct the piggyBac transposase to designated loci, increase vector delivery efficiency,
and improve the utility and safety of the vector for gene therapy. Here we propose to: 1) generate and
validate the function of 'safe harbor' zinc finger protein/piggyBac transposase fusion proteins; 2) map
zinc finger protein/piggyBac transposase mediated transposon integrations in the genome; and 3) create
a hybrid piggyBac/lentivirus vector system to improve delivery efficacy. These studies will provide
important mechanistic information regarding the motifs important for directing piggyBac integrations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spread and Release of Measles in the Airways
-
批准号:10190793
-
项目类别:
-
资助金额:$52.08万
-
财政年份:2018
-
负责人:PATRICK L SINN
-
依托单位:
Spread and Release of Measles in the Airways
-
批准号:10408155
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2018
-
负责人:PATRICK L SINN
-
依托单位:
Life-long phenotypic correction of CF airways
-
批准号:10653542
-
项目类别:
-
资助金额:$76.86万
-
财政年份:2017
-
负责人:PATRICK L SINN
-
依托单位:
A Hybrid Viral/Nonviral Vector for CFTR Delivery to CF Pig Airways
-
批准号:9923461
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2017
-
负责人:PATRICK L SINN
-
依托单位:
Targeted integration of a DNA transposon-based nonviral vector
-
批准号:8237293
-
项目类别:
-
资助金额:$48.21万
-
财政年份:2012
-
负责人:PATRICK L SINN
-
依托单位:
Targeted integration of a DNA transposon-based nonviral vector
-
批准号:8988595
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2012
-
负责人:PATRICK L SINN
-
依托单位:
Targeted integration of a DNA transposon-based nonviral vector
-
批准号:8403682
-
项目类别:
-
资助金额:$45.9万
-
财政年份:2012
-
负责人:PATRICK L SINN
-
依托单位:
Targeted Integration of a Lentiviral Vector
-
批准号:7021573
-
项目类别:
-
资助金额:$11.3万
-
财政年份:2006
-
负责人:PATRICK L SINN
-
依托单位:
Targeted Integration of a Lentiviral Vector
-
批准号:7170056
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2006
-
负责人:PATRICK L SINN
-
依托单位:
Targeted Integration of a Lentiviral Vector
-
批准号:7337315
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2006
-
负责人:PATRICK L SINN
-
依托单位:
Pseudotyping FIV to Target Human Airway Epithelia
-
批准号:6555856
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2002
-
负责人:PATRICK L SINN
-
依托单位:
Pseudotyping FIV to Target Human Airway Epithelia
-
批准号:6340380
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:PATRICK L SINN
-
依托单位:
Viral Vector
-
批准号:10395538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:PATRICK L SINN
-
依托单位:
Viral Vector
-
批准号:10600158
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:PATRICK L SINN
-
依托单位:
Vector Core-Core 2
-
批准号:10225749
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1998
-
负责人:PATRICK L SINN
-
依托单位:
Vector Core-Core 2
-
批准号:10436227
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1998
-
负责人:PATRICK L SINN
-
依托单位:
Vector Core-Core 2
-
批准号:10617353
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1998
-
负责人:PATRICK L SINN
-
依托单位:
Core B: Gene Transfer Vector Core
-
批准号:8935414
-
项目类别:
-
资助金额:$16.61万
-
财政年份:--
-
负责人:PATRICK L SINN
-
依托单位:
Cluster A: 2 Viral Vector Core
-
批准号:9914240
-
项目类别:
-
资助金额:$6.78万
-
财政年份:--
-
负责人:PATRICK L SINN
-
依托单位:
Cluster A: 2 Viral Vector Core
-
批准号:9252404
-
项目类别:
-
资助金额:$5.81万
-
财政年份:--
-
负责人:PATRICK L SINN
-
依托单位:
海外基金